Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (51-60 of 266) with videos related to

Pageof 27
Sort By:
JAMA Neurology|December 17, 2019
The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson DiseaseAlberto J Espay, Robert A Hauser, Melissa J Armstrong
Current Neurology and Neuroscience Reports|July 10, 2007
Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatmentTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
Clinical Parkinsonism & Related Disorders|June 9, 2025
Sedation and sleep safety of pimavanserin for Parkinsons's disease psychosis: Review and exploratory analysis of clinical study dataAna Berrio, Lambros Chrones, Victor Abler, et al.
Journal of Child Neurology|August 12, 2006
Chorea induced by lamotrigineTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
Nature Reviews. Drug Discovery|October 13, 2018
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugsDelphine Charvin, Rossella Medori, Robert A Hauser, et al.
Nature Reviews. Drug Discovery|September 29, 2018
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugsDelphine Charvin, Rossella Medori, Robert A Hauser, et al.
Expert Review of Neurotherapeutics|December 22, 2006
Nonmotor symptoms of Parkinson's diseaseTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
The Neurologist|September 1, 2004
Essential tremor. Epidemiology, diagnosis, and treatmentKelly L Sullivan, Robert A Hauser, Theresa A Zesiewicz
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2005
Vascular hemichorea/hemiballismus and topiramateTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2005
Levetiracetam for the treatment of essential tremorKelly L Sullivan, Robert A Hauser, Theresa A Zesiewicz
Pageof 27

Showing results (51-60 of 266) with videos related to

Sort By:
Pageof 27
JAMA Neurology|December 17, 2019
The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson DiseaseAlberto J Espay, Robert A Hauser, Melissa J Armstrong
Current Neurology and Neuroscience Reports|July 10, 2007
Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatmentTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
Clinical Parkinsonism & Related Disorders|June 9, 2025
Sedation and sleep safety of pimavanserin for Parkinsons's disease psychosis: Review and exploratory analysis of clinical study dataAna Berrio, Lambros Chrones, Victor Abler, et al.
Journal of Child Neurology|August 12, 2006
Chorea induced by lamotrigineTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
Nature Reviews. Drug Discovery|October 13, 2018
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugsDelphine Charvin, Rossella Medori, Robert A Hauser, et al.
Nature Reviews. Drug Discovery|September 29, 2018
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugsDelphine Charvin, Rossella Medori, Robert A Hauser, et al.
Expert Review of Neurotherapeutics|December 22, 2006
Nonmotor symptoms of Parkinson's diseaseTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
The Neurologist|September 1, 2004
Essential tremor. Epidemiology, diagnosis, and treatmentKelly L Sullivan, Robert A Hauser, Theresa A Zesiewicz
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2005
Vascular hemichorea/hemiballismus and topiramateTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2005
Levetiracetam for the treatment of essential tremorKelly L Sullivan, Robert A Hauser, Theresa A Zesiewicz
Pageof 27